Renadyl(2021-06-04)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Natural Health Products - Homeopathic Medicine
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Renadyl
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 5421119B,5420320A,5420720B,5420820 | Renadyl | - Recalling Firm
- Gelda Scientific and Industrial Development Corporation
- 6320 Northwest Drive
- Mississauga
- L4V 1J7
- Ontario
- CANADA
- Marketing Authorization Holder
- Gelda Scientific and Industrial Development Corporation
- 6320 Northwest Drive
- Mississauga
- L4V 1J7
- Ontario
- CANADA
| NPN 80036014 | Capsule | Bifidobacterium longum subsp. longum 15.0 billion cfu |
The affected lots contain an undeclared ingredient (inulin) and are missing risk statements on the label.